Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy Director bought 5,000 shares at $2.22 ($11,100)
  2. 4 Open-market buy EVP, CSO and CMO bought 4,000 shares at $2.20 ($8,800)
  3. 4 Open-market buy President and CEO bought 4,000 shares at $2.24 ($8,960)
  4. 4 Open-market buy Director bought 5,300 shares at an average $2.56 ($13,586)
  5. 4 Open-market buy Director bought 2,000 shares at $2.88 ($5,760)
  6. 4 Open-market buy Director bought 10,200 shares at an average $2.89 ($29,499)
  7. 4 Open-market buy President and CEO bought 6,000 shares at an average $3.04 ($18,260)
  8. 4 Open-market buy EVP, CFO bought 4,000 shares at $2.97 ($11,860)
  9. 4 Open-market buy EVP, CSO and CMO bought 7,000 shares at an average $2.88 ($20,150)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4/A Grant or award Director acquired 7,500 shares (grant or award)
  13. 4/A Grant or award Director acquired 7,500 shares (grant or award)
  14. 4/A Grant or award Director acquired 7,500 shares (grant or award)
  15. 4/A Grant or award Director acquired 7,500 shares (grant or award)
  16. 4/A Grant or award Director acquired 7,500 shares (grant or award)
  17. 4 Open-market buy 10% owner bought 500,000 shares at $2.10 ($1,050,000)
  18. 4 Grant or award Director acquired 7,500 shares (grant or award)
  19. 4 Grant or award Director acquired 7,500 shares (grant or award)
  20. 4 Grant or award Director acquired 7,500 shares (grant or award)

Page 9 of 19 · 362 filings